Israel Englander’s Haemonetics HAE Stock Holding History

Israel Englander’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.5M	Buy	+100,000	New	+$6.42M	﹤0.01%	2601
2025 Q2	–	Sell	-53,600	Closed	-$3.41M	–	6045
2025 Q1	$3.41M	Buy	+53,600	New	+$3.65M	﹤0.01%	3256
2024 Q3	–	Sell	-10,000	Closed	-$827K	–	6240
2024 Q2	$827K	Buy	+10,000	New	+$880K	﹤0.01%	4238
2024 Q1	–	Sell	-10,000	Closed	-$855K	–	6368
2023 Q4	$855K	Buy	+10,000	New	+$865K	﹤0.01%	4276
2022 Q4	–	Sell	-10,000	Closed	-$740K	–	6735
2022 Q3	$740K	Buy	+10,000	New	+$718K	﹤0.01%	4596
2021 Q3	–	Sell	-80,000	Closed	-$5.33M	–	6962
2021 Q2	$5.33M	Buy	+80,000	New	+$5.66M	﹤0.01%	2674
2021 Q1	–	Sell	-50,000	Closed	-$5.94M	–	6153
2020 Q4	$5.94M	Buy	50,000 +30,000	+150%	+$3.23M	﹤0.01%	2273
2020 Q3	$1.75K	Buy	20,000 +5,000	+33%	+$437K	﹤0.01%	2702
2020 Q2	$1.34M	Buy	+15,000	New	+$1.52M	﹤0.01%	2811
2020 Q1	–	Sell	-2,000	Closed	-$230K	–	4105
2019 Q4	$230K	Buy	+2,000	New	+$242K	﹤0.01%	3805
2019 Q2	–	Sell	-20,000	Closed	-$1.75M	–	4197
2019 Q1	$1.75M	Buy	+20,000	New	+$1.82M	﹤0.01%	2503

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's HAE Position: Q2 2026 in Review

Israel Englander increased its Haemonetics (HAE) stake by 5,730% in Q2 2026, buying an estimated $36M and bringing the position to 570,413 shares worth $42.8M. The position accounts for 0.02% of the portfolio, ranked #998.

Israel Englander first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.6M in Q1 2018. 327 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Israel Englander held 570,413 shares of Haemonetics worth $42.8M as of Q2 2026.
Israel Englander bought 560,629 Haemonetics shares in Q2 2026, an estimated $36M.
Haemonetics made up 0.02% of Israel Englander's portfolio in Q2 2026, its #998 holding.
Israel Englander first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
Israel Englander's Haemonetics position peaked at $86.6M in Q1 2018.
327 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.